Teva shed 37% of Israel workforce in two years - Globes
Teva shares plunge as competitors get nod for copycat flagship drug | The Times of Israel
Allergan sells generic drug unit to Israel's Teva for $40.5 billion - Los Angeles Times
Teva's Deal for Mylan Shows Corporate Israel's M&A Hunger - WSJ
Teva Pharmaceuticals: Israeli drugmaker to cut 14,000 jobs - BBC News
Israel's Teva donating potential COVID-19 treatment to US hospitals - ISRAEL21c
Israeli drug company Teva reaches $4.3 billion settlement in US opioid lawsuits | The Times of Israel
Teva strikes 10-year outsourcing deal ahead of closing plant in Israel | Fierce Pharma
Teva to be Sole Distributor of COVID-19 Vaccines in Israel | The Jewish Press - JewishPress.com | Hana Levi Julian | 21 Kislev 5781 – December 6, 2020 | JewishPress.com
Can Israel find a cure for ailing drug giant Teva? – Mishpacha Magazine
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
Exterior of the pharmaceutical manufacturing plant of Teva Pharmaceutical Industries located in Har Hotzvim also called Campus of Science-Rich Industries a high-tech industrial park located in northwest Jerusalem. Israel Stock Photo -
Teva takes 2nd long-acting schizophrenia drug into phase 3
Israel's Teva on FDA blacklist of drugmakers creating barriers to competition | The Times of Israel
Teva Pharmaceuticals Sterile Manufacturing Facility, Ulm - Pharmaceutical Technology
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva Pharmaceutical Industries – The Forward
Teva Pharmaceuticals Office Photos | Glassdoor
Teva, Technion To Collaborate On Cancer, Neurobiology Research
Teva Israel enters medical cannabis market with new partnership | Reuters
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Israeli Drugmaker Teva To Market Medicinal Cannabis Products - I24NEWS
Teva Pharmaceuticals to lay off 14,000 employees worldwide, 1,750 in Israel - The Jerusalem Post
Teva Pharmaceutical Initiated at Market Perform at BMO - TheStreet
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
